Unknown

Dataset Information

0

Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice.


ABSTRACT: Mesenchymal stem/stromal cells (MSCs) are cultured adult stem cells that originally reside in virtually all tissues, and the gain of MSCs by transplantation has become the leading form of cell therapy in various diseases. However, there is limited knowledge on the alteration of its efficacy by factors in recipients. Here, we report that the cardioprotective properties of intravenously injected MSCs in a mouse model of pressure-overload heart failure largely depend on circulating adiponectin, an adipocyte-secreted factor. The injected MSCs exert their function through exosomes, extracellular vesicles of endosome origin. Adiponectin stimulated exosome biogenesis and secretion through binding to T-cadherin, a unique glycosylphosphatidylinositol-anchored cadherin, on MSCs. A pharmacological or adenovirus-mediated genetic increase in plasma adiponectin enhanced the therapeutic efficacy of MSCs. Our findings provide novel insights into the importance of adiponectin in mesenchymal-progenitor-mediated organ protections.

SUBMITTER: Nakamura Y 

PROVIDER: S-EPMC7351027 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice.

Nakamura Yuto Y   Kita Shunbun S   Tanaka Yoshimitsu Y   Fukuda Shiro S   Obata Yoshinari Y   Okita Tomonori T   Nishida Hiroyuki H   Takahashi Yuki Y   Kawachi Yusuke Y   Tsugawa-Shimizu Yuri Y   Fujishima Yuya Y   Nishizawa Hitoshi H   Takakura Yoshinobu Y   Miyagawa Shigeru S   Sawa Yoshiki Y   Maeda Norikazu N   Shimomura Iichiro I  

Molecular therapy : the journal of the American Society of Gene Therapy 20200710 10


Mesenchymal stem/stromal cells (MSCs) are cultured adult stem cells that originally reside in virtually all tissues, and the gain of MSCs by transplantation has become the leading form of cell therapy in various diseases. However, there is limited knowledge on the alteration of its efficacy by factors in recipients. Here, we report that the cardioprotective properties of intravenously injected MSCs in a mouse model of pressure-overload heart failure largely depend on circulating adiponectin, an  ...[more]

Similar Datasets

| S-EPMC5748110 | biostudies-literature
| S-EPMC5352458 | biostudies-literature
| S-EPMC2803144 | biostudies-literature
| S-EPMC5931116 | biostudies-literature
| S-EPMC7068154 | biostudies-literature
| S-EPMC5436520 | biostudies-literature
| S-EPMC6683124 | biostudies-literature
2013-08-06 | E-GEOD-48112 | biostudies-arrayexpress
| S-EPMC6171656 | biostudies-other
2013-08-06 | E-GEOD-48110 | biostudies-arrayexpress